Effects of simultaneous versus post exposure epigallocatechin-3-gallate treatment on aluminum induced neurotoxicity in rat hippocampus: A multi-approach study

Environ Toxicol Pharmacol. 2023 Mar:98:104061. doi: 10.1016/j.etap.2023.104061. Epub 2023 Jan 6.

Abstract

Chronic aluminium(Al) exposure can affect the antioxidant and glutaminergic systems through N-methyl-D-aspartate receptors (NMDAR). This study was aimed to investigate the neurotoxic effect of Al through different mechanisms in rat hippocampus and to evaluate the protective role of epigallocatechin gallate (EGCG), a well-known antioxidant, with simultaneous administration of Al,as well as post-treatment after Al exposure.For this purpose, aluminum chloride(AlCl3) was administered simultaneously with two different EGCG doses for 8 weeks as the first part of the study.In the second part of the study, after 4 weeks of AlCl3 pre-administration, two different EGCG doses were also administered during four additional weeks as post-treatment.Al administration led to oxidative stress and increased acetylcholinesterase levels.NMDAR subunit mRNA expressions were down-regulated by Al, which was apparent in NMDAR1/2B subunits.Simultaneous EGCG treatment has shown a better neuroprotective effect in terms of these mechanisms and represents novel approach for the prevention of neurodegenerative diseases likely to be induced by Al.

Keywords: Aluminum; Epigallocatechin gallate; NMDAR; Neurotoxicity.

MeSH terms

  • Acetylcholinesterase / metabolism
  • Aluminum / toxicity
  • Animals
  • Antioxidants / pharmacology
  • Catechin* / pharmacology
  • Catechin* / therapeutic use
  • Hippocampus
  • Neuroprotective Agents* / pharmacology
  • Neurotoxicity Syndromes* / drug therapy
  • Oxidative Stress
  • Rats
  • Rats, Wistar

Substances

  • Aluminum
  • Antioxidants
  • epigallocatechin gallate
  • Acetylcholinesterase
  • Catechin
  • Neuroprotective Agents